Health Boards
Wed-14-02-2018, 23:04 PM
That's interesting to read about the Taltz but also interesting the mirikizumab phase 2 study of efficacy of it for moderate to severe psoriasis ....I see it targets IL-23 so could show good results
It looks as if Eli Lilly will be doing some interesting presentations including on quality of life for sufferers at the meeting
It looks as if Eli Lilly will be doing some interesting presentations including on quality of life for sufferers at the meeting
